Literature DB >> 23041963

Exercise intensity and lymphocyte subset apoptosis.

J W Navalta1, S Lyons, J Prestes, S W Arnett, M Schafer, G L Sobrero.   

Abstract

This investigation assessed the lymphocyte subset response to increasing intensity. Participants completed an exertion test (VO(2max)), and later performed a 10-min run at 76% VO(2max), 5-min at 87%, and run to exhaustion at 100% intensity. Blood was sampled at rest, following each intensity, and 1-h post. Cell concentration, apoptosis (annexin V) and migration (CX₃CR1) were evaluated in CD4+, CD8+, and CD19+ subsets. Relative data were analyzed using 1-way ANOVA with significance at P≤0.05. Absolute changes from rest (Δ baseline) were calculated for exercise conditions. CX₃CR1 displayed relative changes 1-h post, (CD8+ Pre=58%, Post=68%, 1 h-Post=37%, P=0.04) (CD19+ Pre=1.9%, Post=3.2%, 1 h-Post=5.2%, P=0.02). No relative changes were noted for subsets and annexin V. Absolute changes revealed that CD4+/annexin V+ and CD8+/annexin V+ significantly increased at 76%,(P<0.01). Significant absolute increases were observed in CD4+/CX₃CR1 at 87% VO2max, and at 87% and 100% VO2max in CD8+/CX₃CR1 (P<0.01). Subsets respond differently with intensity with respect to cell count, and markers of apoptosis and cell migration. CD4+ and CD8+ appear to be prone to apoptosis with moderate exercise, but significant increases in migration at higher intensities suggests movement of these cells from the vasculature in postexercise measurements. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041963     DOI: 10.1055/s-0032-1312581

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  8 in total

1.  Caffeine affects CD8+ lymphocyte apoptosis and migration differently in naïve and familiar individuals following moderate intensity exercise.

Authors:  James W Navalta; Elizabeth A Fedor; Mark A Schafer; T Scott Lyons; Ramires A Tibana; Guilherme B Pereira; Jonato Prestes
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

2.  The Effect of a Competitive Futsal Match on T Lymphocyte Surface Receptor Signaling and Functions.

Authors:  Maria F Cury-Boaventura; Renata Gorjão; Nivaldo R de Moura; Vinicius C Santos; José R Bortolon; Gilson M Murata; Leandro da Silva Borges; César M Momesso; Alexandre Dermargos; Tania C Pithon-Curi; Elaine Hatanaka
Journal:  Front Physiol       Date:  2018-03-15       Impact factor: 4.566

3.  T-regulatory cells exhibit a biphasic response to prolonged endurance exercise in humans.

Authors:  Tom Clifford; Matthew J Wood; Philip Stocks; Glyn Howatson; Emma J Stevenson; Catharien M U Hilkens
Journal:  Eur J Appl Physiol       Date:  2017-06-23       Impact factor: 3.078

4.  Post-match recovery profile of leukocyte cell subsets among professional soccer players.

Authors:  Dorota Kostrzewa-Nowak; Paweł Wityk; Andrzej Ciechanowicz; Robert Nowak
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

5.  Effects of unaccustomed downhill running on muscle damage, oxidative stress, and leukocyte apoptosis.

Authors:  Kyung-Shin Park; Man-Gyoon Lee
Journal:  J Exerc Nutrition Biochem       Date:  2015-06-30

6.  Three consecutive days of interval runs to exhaustion affects lymphocyte subset apoptosis and migration.

Authors:  James W Navalta; Ramires Alsamir Tibana; Elizabeth A Fedor; Amilton Vieira; Jonato Prestes
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

7.  Assessment of Selected Exercise-induced CD3+ Cell Subsets and Cell Death Parameters Among Soccer Players.

Authors:  Robert Nowak; Dorota Kostrzewa-Nowak
Journal:  J Med Biochem       Date:  2019-03-26       Impact factor: 3.402

8.  Comparison of the lymphocyte response to interval exercise versus continuous exercise in recreationally trained men.

Authors:  Eliott Arroyo; Emily C Tagesen; Tricia L Hart; Brandon A Miller; Adam R Jajtner
Journal:  Brain Behav Immun Health       Date:  2022-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.